ClinicalTrials.gg
Drug

Aprepitant clinical trials

Also written Emend, MK-0869 and ONO-7436.

studies test it
128
open now
8
in phase 3
36
first study started
2001

Counted the way a researcher would: Aprepitant with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Aprepitant is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Aprepitant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
26 Mar 2003 · EMEND · NDA 021549 (FDA, Drugs@FDA)
European Union
11 Nov 2003 · Emend · EMEA/H/C/000527 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aprepitant
81
Aprepitant 125 mg
5
Aprepitant Injection
4
MK0869, aprepitant
4
Aprepitant 80 mg
3

Brand

Emend
47

Development codes

MK-0869
12
ONO-7436
4
MK-869
2
L-754,030
1

In one entry with another drug

Given together, or one or the other

ramosetron, aprepitant, dexamethasone
2
Aprepitant + Dexamethasone
2

Studies by the year they started

127 studies that test it; most in 2011 (13)

Studies that test Aprepitant, by start year
YearStudies
20015
20024
20043
20055
20064
20079
20087
20099
20108
201113
20126
20134
20149
20158
20163
20176
20182
20194
20211
20223
20232
20246
20252
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
14
Phase 2
26
Phase 3
36
Phase 4
29
No phase
22

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 103

Merck Sharp & Dohme LLC (19) · Sun Yat-sen University (4) · University of Pennsylvania (4) · The Hospital for Sick Children (2) · Vanderbilt University (2) · NYU Langone Health (2) · Mayo Clinic (2) · Dartmouth-Hitchcock Medical Center (2)

Often tested with

Tested in the same studies.

Dexamethasone (19) · Ondansetron (13) · Fosaprepitant (8) · Palonosetron (7) · Granisetron (5) · Olanzapine (3) · Ramosetron (3) · Cyclophosphamide (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test Aprepitant.

Studies

Open first, then newest update. How each study uses Aprepitant is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 128

See all 128 studies that test Aprepitant →

Given beside what is tested · 16 — Aprepitant is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with Aprepitant

Codes

What other systems call Aprepitant · ClinicalTrials.gg INT006778

  • MeSH (NLM) D000077608AprepitantConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1NF15YR6UYAPREPITANTConfirmed FDA, NLM, Wikidata
  • RxNorm 358255Confirmed FDA, Wikidata
  • Wikidata Q621834aprepitantConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C49173AprepitantOne source FDA
  • DrugBank DB00673One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.